معرفی
Kim Thomsen serves as a Clinical Associate Professor in the Department of Clinical Medicine at the Faculty of Health and Medical Sciences, University of Copenhagen, with research activities centered at Rigshospitalet (Blegdamsvej 3, Copenhagen). His work bridges clinical practice and laboratory research within infectious disease management.
His primary research focuses on combating Pseudomonas aeruginosa infections through innovative approaches including AI-driven vaccine development and bacteriophage therapy. Specialized in biofilm-associated infections in pulmonary and orthopedic contexts, his work addresses critical antimicrobial resistance challenges with translational applications. Key methodologies involve murine infection models and clinical case studies targeting treatment-resistant prosthetic infections.
Recent publications (2024-2025) reveal a concentrated effort on therapeutic alternatives for multidrug-resistant pathogens, emphasizing preclinical vaccine validation and real-world bacteriophage applications. This research trajectory demonstrates strong international collaboration patterns across European institutions, particularly in Denmark and Belgium.
Scientific awards: No honors or fellowships were documented in the provided materials.
Academic advising and grant activities remain unspecified in available records, though active co-authorship patterns suggest ongoing mentorship roles. Collaboration networks indicate involvement with clinical microbiology teams at Region Sjælland and international phage therapy consortia.
Laboratory affiliations appear connected to university hospital research units specializing in biofilm infections, with emphasis on translational pipelines from bench to bedside for antibiotic-resistant pathogens.
